Switching from an SSRI to an SNRI typically involves gradually tapering off the SSRI under a doctor’s guidance and starting the SNRI at a low dose. Switching from a selective serotonin reuptake ...

Researchers analysed and then meta-analysed data from two register-based, nationwide cohort studies in Finland (1996-2017) and Sweden (2006-2023) and included 23,206 patients with schizophrenia (mean ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of disability and low quality of life. One in every three people suffering from MDD ...

Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than ...

Depression and anxiety are among the most common mental health conditions in the world. They can affect how people think, ...

Major depressive disorder (MDD) is a severe form of depression characterized by a persistent low mood, hopelessness, disruptions in sleep and/or eating habits, as well as a loss of motivation and ...

Compared with no antidepressant use, there was a significantly reduced risk of non-exudative AMD and exudative AMD with use of SSRIs, SNRIs, or tricyclic antidepressants. Depression and AMD share ...

Approximately one in nine American adults takes an antidepressant (AD), the prescriptions written not by psychiatrists but by primary-care clinicians, internists, family physicians, and nurse ...

You've tried everything to feel like yourself again. You've done talk therapy, made time to get outside every day, listened ...